美国研究综述-Crowdstrike、FactSet、Rivian

路透中文15:52

美国研究综述-Crowdstrike、FactSet、<a href="https://laohu8.com/S/RIVN">Rivian</a>

路透7月3日 - 周五，华尔街证券分析师上调了包括Crowdstrike、Factset和Rivian在内的几家美国上市公司评级及目标股价。

要点

* Crowdstrike CRWD.O：Canaccord Genuity将目标价从168.75美元上调至185美元

* Factset FDS.N：杰富瑞将目标价从225美元上调至253美元

* Rivian RIVN.O：摩根大通将目标价从9美元上调至15美元

以下是路透周五报导的针对美国公司的研究行动摘要。股票条目按字母顺序排列。

* 星座品牌（Constellation Brands） STZ.N：汇丰将目标价从190美元上调至192美元

* Crowdstrike CRWD.O：Canaccord Genuity将目标价从168.75美元上调至185美元

* Factset FDS.N：杰富瑞将目标价从225美元上调至253美元

* 通用磨坊公司 GIS.N：汇丰将目标价从44美元下调至41美元

* Procept Biorobotics Corp PRCT.O：Truist Securities将评级从“买入”下调至“持有”

* Procept Biorobotics Corp PRCT.O：Truist证券将目标价从30美元下调至25美元

* Rivian RIVN.O：摩根大通将目标价从9美元上调至15美元

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2648651121?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-03 15:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648651121","market":"us","top_or_hot":-1,"title":"美国研究综述-Crowdstrike、FactSet、Rivian","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美国研究综述-Crowdstrike、FactSet、<a href=\"https://laohu8.com/S/RIVN\">Rivian</a></title></head><body><p><span>路透7月3日</span><span> - </span>周五，华尔街证券分析师上调了包括Crowdstrike、Factset和Rivian在内的几家美国上市公司评级及目标股价。 </p><p>要点 </p><table><tbody><tr><td><p><span> * Crowdstrike <span><a href=\"https://laohu8.com/S/CRWD\">CRWD</a>.O</span>：<a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a>将目标价从168.75美元上调至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：<a href=\"https://laohu8.com/S/JEF\">杰富瑞</a>将目标价从225美元上调至253美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>将目标价从9美元上调至15美元</span></p></td></tr></tbody></table><p>以下是路透周五报导的针对美国公司的研究行动摘要。股票条目按字母顺序排列。  </p><table><tbody><tr><td><p><span> * <a href=\"https://laohu8.com/S/STZ\">星座品牌</a>（<a href=\"https://laohu8.com/S/CEG\">Constellation</a> Brands） <span>STZ.N</span>：<a href=\"https://laohu8.com/S/HSBC\">汇丰</a>将目标价从190美元上调至192美元</span></p></td></tr><tr><td><p><span> * Crowdstrike <span>CRWD.O</span>：Canaccord Genuity将目标价从168.75美元上调至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：杰富瑞将目标价从225美元上调至253美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/GIS\">通用磨坊</a>公司 <span>GIS.N</span>：<a href=\"https://laohu8.com/S/00005\">汇丰</a>将目标价从44美元下调至41美元</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist Securities将评级从“买入”下调至“持有”</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist证券将目标价从30美元下调至25美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：摩根大通将目标价从9美元上调至15美元</span></p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国研究综述-Crowdstrike、FactSet、Rivian</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国研究综述-Crowdstrike、FactSet、Rivian\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-07-03 15:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美国研究综述-Crowdstrike、FactSet、<a href=\"https://laohu8.com/S/RIVN\">Rivian</a></title></head><body><p><span>路透7月3日</span><span> - </span>周五，华尔街证券分析师上调了包括Crowdstrike、Factset和Rivian在内的几家美国上市公司评级及目标股价。 </p><p>要点 </p><table><tbody><tr><td><p><span> * Crowdstrike <span><a href=\"https://laohu8.com/S/CRWD\">CRWD</a>.O</span>：<a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a>将目标价从168.75美元上调至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：<a href=\"https://laohu8.com/S/JEF\">杰富瑞</a>将目标价从225美元上调至253美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>将目标价从9美元上调至15美元</span></p></td></tr></tbody></table><p>以下是路透周五报导的针对美国公司的研究行动摘要。股票条目按字母顺序排列。  </p><table><tbody><tr><td><p><span> * <a href=\"https://laohu8.com/S/STZ\">星座品牌</a>（<a href=\"https://laohu8.com/S/CEG\">Constellation</a> Brands） <span>STZ.N</span>：<a href=\"https://laohu8.com/S/HSBC\">汇丰</a>将目标价从190美元上调至192美元</span></p></td></tr><tr><td><p><span> * Crowdstrike <span>CRWD.O</span>：Canaccord Genuity将目标价从168.75美元上调至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：杰富瑞将目标价从225美元上调至253美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/GIS\">通用磨坊</a>公司 <span>GIS.N</span>：<a href=\"https://laohu8.com/S/00005\">汇丰</a>将目标价从44美元下调至41美元</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist Securities将评级从“买入”下调至“持有”</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist证券将目标价从30美元下调至25美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：摩根大通将目标价从9美元上调至15美元</span></p></td></tr></tbody></table></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2023250504.SGD","symbol_name":"Allianz Thematica Cl AMg DIS H2-SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL4T4350HA:1","article_id":"2648651121","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648651121","pubTimestamp":1783065127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"美国研究综述-Crowdstrike、FactSet、Rivian路透7月3日-周五，华尔街证券分析师上调了包括Crowdstrike、Factset和Rivian在内的几家美国上市公司评级及目标股价。要点* CrowdstrikeCRWD.O：Canaccord Genuity将目标价从168.75美元上调至185美元* FactsetFDS.N：杰富瑞将目标价从225美元上调至253美元* RivianRIVN.O：摩根大通将目标价从9美元上调至15美元以下是路透周五报导的针对美国公司的研究行动摘要。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","BK4547":"WSB热门概念","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0081259029.USD":"UBS (LUX) EQUITY FUND - TECH OPPORTUNITY \"P\" (USD) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","CRWD":"CrowdStrike Holdings, Inc.","BK4596":"哈里斯概念","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4504":"桥水持仓","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1548497426.USD":"安联环球人工智能AT Acc","RVNL":"2倍做多RIVN ETF-GraniteShares","PRCT":"PROCEPT BioRobotics","BK4588":"碎股","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","LU2125909759.SGD":"Natixis Thematics Safety H-R/A SGD","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","STZ":"星座品牌","FDS":"辉盛研究系统","RIVN":"Rivian Automotive, Inc.","GIS":"通用磨坊","BK4169":"酿酒商与葡萄酒商","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2125909916.SGD":"Natixis Thematics Safety R/A SGD","BK4551":"寇图资本持仓","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","BK4598":"佩洛西持仓","LU1923622291.USD":"Natixis Thematics Safety R/A USD","BK4112":"金融交易所和数据","BK4097":"系统软件","BK4532":"文艺复兴科技持仓","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4543":"AI","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","CRWL":"2倍做多CRWD ETF-GraniteShares","BK4567":"ESG概念","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","BK4555":"新能源车","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD"},"translate_title":"U.S. Research Roundup-CrowdStrike, FactSet, Rivian","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STZ":0.9,"FDS":0.9,"RIVN":0.9,"CRWL":0.6,"PRCT":0.9,"GIS":0.9,"RVNL":0.6,"CRWD":0.9},"content_text":"美国研究综述-Crowdstrike、FactSet、Rivian路透7月3日 - 周五，华尔街证券分析师上调了包括Crowdstrike、Factset和Rivian在内的几家美国上市公司评级及目标股价。 要点  * Crowdstrike CRWD.O：Canaccord Genuity将目标价从168.75美元上调至185美元 * Factset FDS.N：杰富瑞将目标价从225美元上调至253美元 * Rivian RIVN.O：摩根大通将目标价从9美元上调至15美元以下是路透周五报导的针对美国公司的研究行动摘要。股票条目按字母顺序排列。   * 星座品牌（Constellation Brands） STZ.N：汇丰将目标价从190美元上调至192美元 * Crowdstrike CRWD.O：Canaccord Genuity将目标价从168.75美元上调至185美元 * Factset FDS.N：杰富瑞将目标价从225美元上调至253美元 * 通用磨坊公司 GIS.N：汇丰将目标价从44美元下调至41美元 * Procept Biorobotics Corp PRCT.O：Truist Securities将评级从“买入”下调至“持有” * Procept Biorobotics Corp PRCT.O：Truist证券将目标价从30美元下调至25美元 * Rivian RIVN.O：摩根大通将目标价从9美元上调至15美元","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648651121","isCrawlerRequest":true}